MedWatch

Here are the challenges awaiting the new CEO at Lundbeck

Analysis: Kåre Schultz and Anders Götszche put Lundbeck's finances in order. Yet, several major tasks await Deborah Dunsire, who took position as new CEO in the Danish drug group this week.

Foto: Lundbeck

Analysis: After almost a year with no permanent top manager, Danish drug group Lundbeck was the center of attention earlier this week, when Deborah Dunsire (56) from South Africa took position as the company's new CEO.

Although she is joining a well-managed and highly profitable company - at fact that has excited investors and analysts during the past years - the new CEO is facing a somewhat more complicated task than former chief Kåre Schultz did in 2015.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier